This is one of the biggest peptide regulatory updates in years, and it's just the beginning. The FDA has officially initiated the first step to reverse its 2023 stance, removing 12 peptides Best Way to Take BPC 157: Dosage & Administration FDA to Convene Pharmacy Compounding Advisory Committee in July FDA Peptide Reclassification 2026: What Researchers Want FDA Moves to Exclude Semaglutide, Tizerpatide, and Liraglutide from 503B Bulk Substances List Lengea